Search
for
Sort by
Research 61–90 of 609
- Genetic Defects of Female Sexual Differentiation
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Obesity and polycystic ovary syndrome
- Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review
- The role of androgen and androgen receptor in skin-related disorders
- Role of Environmental Factors and Gonadotoxin Exposure in Unexplained Male Infertility
- Genetic, hormonal and metabolic aspects of PCOS: an update
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Male fertility and skin diseases
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Androgen effects on the skin
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- An Update of Congenital Adrenal Hyperplasia
- Ovarian Hypertension: Polycystic Ovary Syndrome
- 46,XY DSD due to impaired androgen production
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Polycystic ovarian syndrome
- Gender difference in relationship between serum ferritin and 25-hydroxyvitamin D in Korean adults
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The impact of obesity on the folliculosebaceous unit
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Exploring the therapeutic potential of metformin in polycystic ovary syndrome: focusing on hyperandrogenism in a sample of Iraqi women
- Androgen excess: a hallmark of polycystic ovary syndrome
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- Modelling androgen synthesis and action during human sexual differentiation